Beam Therapeutics Inc. [●] Shares of Common Stock Underwriting AgreementUnderwriting Agreement • September 28th, 2020 • Beam Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 28th, 2020 Company Industry JurisdictionBeam Therapeutics Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] shares of common stock, par value $0.01 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [●] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.